These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29020046)

  • 1. Mid-infrared spectroscopy of serum, a promising non-invasive method to assess prognosis in patients with ascites and cirrhosis.
    Le Corvec M; Jezequel C; Monbet V; Fatih N; Charpentier F; Tariel H; Boussard-Plédel C; Bureau B; Loréal O; Sire O; Bardou-Jacquet E
    PLoS One; 2017; 12(10):e0185997. PubMed ID: 29020046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of Ascites and Serum Sodium in Patients with Low Meld Scores.
    Prohic D; Mesihovic R; Vanis N; Puhalovic A
    Med Arch; 2016 Feb; 70(1):48-52. PubMed ID: 26980932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
    Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
    Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH; Liu HB; Wang Y; Wang BY; Song M; Sun MJ
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
    Heuman DM; Abou-Assi SG; Habib A; Williams LM; Stravitz RT; Sanyal AJ; Fisher RA; Mihas AA
    Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of C-reactive protein in cirrhosis: external validation from the CANONIC cohort.
    Cervoni JP; Amorós À; Bañares R; Luis Montero J; Soriano G; Weil D; Moreau R; Pavesi M; Thévenot T; Di Martino V;
    Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):1028-34. PubMed ID: 27271159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of insulin-like growth factor 1-Child-Turcotte-Pugh score for mortality in patients with decompensated cirrhosis.
    Yao Y; Yang D; Huang Y; Dong M
    Clin Chim Acta; 2020 Jun; 505():141-147. PubMed ID: 32119835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human serum fetuin A/alpha2HS-glycoprotein level is associated with long-term survival in patients with alcoholic liver cirrhosis, comparison with the Child-Pugh and MELD scores.
    Kalabay L; Gráf L; Vörös K; Jakab L; Benko Z; Telegdy L; Fekete B; Prohászka Z; Füst G
    BMC Gastroenterol; 2007 Mar; 7():15. PubMed ID: 17394649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fiber evanescent wave spectroscopy using the mid-infrared provides useful fingerprints for metabolic profiling in humans.
    Anne ML; Le Lan C; Monbet V; Boussard-Plédel C; Ropert M; Sire O; Pouchard M; Jard C; Lucas J; Adam JL; Brissot P; Bureau B; Loréal O
    J Biomed Opt; 2009; 14(5):054033. PubMed ID: 19895135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Child-Pugh, MELD, and ALBI scores for predicting the in-hospital mortality in cirrhotic patients with acute-on-chronic liver failure.
    Peng Y; Qi X; Tang S; Deng H; Li J; Ning Z; Dai J; Hou F; Zhao J; Wang R; Guo X
    Expert Rev Gastroenterol Hepatol; 2016 Aug; 10(8):971-80. PubMed ID: 27070325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Metabolic Liver Function Tests: a Study on 711 Cirrhotic Patients.
    Lebossé F; Guillaud O; Forestier J; Ecochard M; Boillot O; Roman S; Mion F; Dumortier J
    J Gastrointestin Liver Dis; 2016 Sep; 25(3):337-43. PubMed ID: 27689198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
    Giannini E; Botta F; Fumagalli A; Malfatti F; Testa E; Chiarbonello B; Polegato S; Bellotti M; Milazzo S; Borgonovo G; Testa R
    Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of creatinine-modified Child Pugh score for predicting short-term prognosis of patients with decompensated cirrhosis of liver as compare to original child Pugh score.
    Samiullah S; Qasim R; Khalid S; Hussain BG; Mukhtair J; Akbar Y
    J Ayub Med Coll Abbottabad; 2009; 21(2):64-7. PubMed ID: 20524472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MELD era: is this time to replace the original Child-Pugh score in patients with decompensated cirrhosis of liver.
    Shaikh S; Ghani H; Memon S; Baloch GH; Jaffery M; Shaikh K
    J Coll Physicians Surg Pak; 2010 Jul; 20(7):432-5. PubMed ID: 20642940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions.
    Rahimi-Dehkordi N; Nourijelyani K; Nasiri-Tousi M; Ghodssi-Ghassemabadi R; Azmoudeh-Ardalan F; Nedjat S
    Arch Iran Med; 2014 Feb; 17(2):118-21. PubMed ID: 24527973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis.
    Luca A; Angermayr B; Bertolini G; Koenig F; Vizzini G; Ploner M; Peck-Radosavljevic M; Gridelli B; Bosch J
    Liver Transpl; 2007 Aug; 13(8):1174-80. PubMed ID: 17663415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.
    Cheng XP; Zhao J; Chen Y; Meng FK; Xu B; Yu HW; Meng QH; Liu YM; Zhang SB; Meng S; Zhang JY; Zhang JY; Duan ZP; Zheng SJ
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):444-8. PubMed ID: 26649802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding.
    Reverter E; Tandon P; Augustin S; Turon F; Casu S; Bastiampillai R; Keough A; Llop E; González A; Seijo S; Berzigotti A; Ma M; Genescà J; Bosch J; García-Pagán JC; Abraldes JG
    Gastroenterology; 2014 Feb; 146(2):412-19.e3. PubMed ID: 24148622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.